Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Favorite
Like
Facebook
Tweet
Print
HYORYEONG JIN
Republic of Korea
Poster(s):
(8-084) Multivariate Analysis of Primary Resistance in Metastatic Colorectal Cancer with EGFR(+), Ras Wild-type, Chemotherapy with mFOLFOX or FOLFIRI combined with Bevacizumab/Cetuximab a Single Medical Institution
Tuesday, December 10, 2024
2:00 PM – 3:30 PM